Principal Investigator
Rani George, M.D., Ph.D.
Associate Professor of Pediatrics
Harvard Medical School
Dana 640
rani_george@dfci.harvard.edu
Associate Professor of Pediatrics
Harvard Medical School
Dana 640
rani_george@dfci.harvard.edu
Present Members
Bandana Sharma, Ph.D.
Lab Manager
Dana 640A
bandana_sharma@dfci.harvard.edu
Lab Manager
Dana 640A
bandana_sharma@dfci.harvard.edu
Hao Huang, Ph.D.
Louisiana State University Postdoctoral Fellow Recipient, Grant Team Path to the Cure hao_huang@dfci.harvard.edu |
"My research project focuses on the molecular biology and biochemistry research of ALK, a Receptor Tyrosine Kinase closely related to neuroblastoma."
|
Satyaki Sengupta, Ph.D.
Michigan State University Postdoctoral Fellow Fellow, Rally Foundation for Childhood Cancer Research and Infinite Love for Kids Fighting Cancer (2019-2021) satyaki_sengupta@dfci.harvard.edu |
"My interests are vested in understanding chromatin features underlying aberrant gene expression in neuroblastoma (NB). The broad goal is to uncover the role of chromatin in driving the hallmark features of NB such as aberrant proliferation, impaired differentiation and immune evasion."
|
Matthew Harlow, Ph.D.
Vanderbilt University Postdoctoral Fellow Recipient, What Would Willie Want Foundation Fellowship matthew_harlow@dfci.harvard.edu |
"I am interested in understanding the transcriptional processes that lead to tumor formation. In particular, I want to identify transcriptional dependencies that can be leveraged into improving patient outcomes."
|
Sanjukta Das, Ph.D.
Indian Institute of Science, Bangalore Postdoctoral Fellow sanjukta_das@dfci.harvard.edu |
"I use integrative computational and statistical methods to analyze genomics and transcriptomics data in order to understand the underlying mechanism of transcription and molecular pathways in tumors."
|
Marina Volegova, Ph.D.
University of California - Berkeley Postdoctoral Fellow marina_volegova@dfci.harvard.edu |
"My research focus is to investigate how cellular mRNA translation machinery and amplified MYCN in high risk neuroblastoma synergize at the level of translation regulation to drive unique gene expression programs to evade apoptosis and potentiate oncogenic activity."
|
Cibele Cardoso, Ph.D.
University of Sao Paulo Postdoctoral Fellow cibele_cardoso@dfci.harvard.edu 
Rodolfo Serafim, Ph.D.
University of Sao Paulo Postdoctoral Fellow RodolfoB_Serafim@dfci.harvard.edu 
Alissa Joy
Administrative Assistant Dana 640 (617) 582-8633 AlissaL_Joy@dfci.harvard.edu |
"My research interest is to investigate the molecular basis of BORIS as an epigenetic modulator of therapeutic resistance and cancer aggressiveness."
"I am focused on understanding the molecular mechanisms of genomic instability and epigenetic alterations in osteosarcoma.” |
Esther Dolz, MSc
University of Applied Sciences, Vienna Research Technician Dana 640 Esther_Dolz@dfci.harvard.edu |
